» Articles » PMID: 26823560

EEF1D Modulates Proliferation and Epithelial-mesenchymal Transition in Oral Squamous Cell Carcinoma

Abstract

EEF1D (eukaryotic translation elongation factor 1δ) is a subunit of the elongation factor 1 complex of proteins that mediates the elongation process during protein synthesis via enzymatic delivery of aminoacyl-tRNAs to the ribosome. Although the functions of EEF1D in the translation process are recognized, EEF1D expression was found to be unbalanced in tumours. In the present study, we demonstrate the overexpression of EEF1D in OSCC (oral squamous cell carcinoma), and revealed that EEF1D and protein interaction partners promote the activation of cyclin D1 and vimentin proteins. EEF1D knockdown in OSCC reduced cell proliferation and induced EMT (epithelial-mesenchymal transition) phenotypes, including cell invasion. Taken together, these results define EEF1D as a critical inducer of OSCC proliferation and EMT.

Citing Articles

Plectin-mediated cytoskeletal crosstalk as a target for inhibition of hepatocellular carcinoma growth and metastasis.

Outla Z, Oyman-Eyrilmez G, Korelova K, Prechova M, Frick L, Sarnova L Elife. 2025; 13.

PMID: 40052672 PMC: 11893104. DOI: 10.7554/eLife.102205.


Plectin: Dual Participation in Tumor Progression.

Wang Z, Wang W, Luo Q, Song G Biomolecules. 2024; 14(9).

PMID: 39334817 PMC: 11430127. DOI: 10.3390/biom14091050.


The eEF1 family of mammalian translation elongation factors.

Negrutskii B, Shalak V, Novosylna O, Porubleva L, Lozhko D, Elskaya A BBA Adv. 2023; 3:100067.

PMID: 37082266 PMC: 10074971. DOI: 10.1016/j.bbadva.2022.100067.


Stress induced phosphoprotein 1 overexpression controls proliferation, migration and invasion and is associated with poor survival in oral squamous cell carcinoma.

Dourado M, Elseragy A, da Costa B, Teo F, Guimaraes G, Machado R Front Oncol. 2023; 12:1085917.

PMID: 36713524 PMC: 9874128. DOI: 10.3389/fonc.2022.1085917.


Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin.

Xu Q, Liu Y, Wang S, Wang J, Liu L, Xu Y BMC Cancer. 2022; 22(1):628.

PMID: 35672728 PMC: 9175347. DOI: 10.1186/s12885-022-09699-7.